Autophagic Flux

Autophagic Flux describes the complete autophagy process including autophagosome formation, cargo sequestration, lysosomal fusion, content degradation, and nutrient recycling, representing a critical cellular quality control and survival mechanism responding to nutrient deprivation, stress, or accumulation of damaged cellular components.

The biopharmaceutical industry investigates autophagic flux in cancer biology, neurodegeneration, and infectious diseases where dysregulated autophagy contributes to pathogenesis or drug resistance. Autophagy inhibitors like chloroquine disrupt lysosomal function, exploring therapeutic potential in cancer combination regimens. mTOR inhibitors induce autophagy as downstream consequences of pathway inhibition. Measuring autophagic flux accurately requires multiple complementary assays distinguishing enhanced autophagosome formation from impaired degradation. As understanding deepens regarding autophagy roles in disease biology and drug response, autophagy modulation continues generating therapeutic interest across multiple oncology and neurodegenerative disease indications.